Skip to main navigation Skip to search Skip to main content

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.

  • Axel Benner
  • , Larry Mansouri
  • , Davide Rossi
  • , Aneela Majid
  • , Kerstin Willander
  • , Anton Parker
  • , Gareth Bond
  • , Sarka Pavlova
  • , Holger Nückel
  • , Olaf Merkel
  • , Paolo Ghia
  • , Emili Montserrat
  • , Mohd Arifin Kaderi
  • , Richard Rosenquist
  • , Gianluca Gaidano
  • , Martin J S Dyer
  • , Peter Söderkvist
  • , Mats Linderholm
  • , David Oscier
  • , Zuzana Tvaruzkova
  • Sarka Pospisilova, Ulrich Dührsen, Richard Greil (Co-author), Hartmut Döhner, Stephan Stilgenbauer, Thorsten Zenz

Research output: Contribution to journalOriginal Articlepeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1285-1291
JournalHAEMATOLOGICA
Volume99
Issue number8
DOIs
Publication statusPublished - 2014

Keywords

  • SINGLE NUCLEOTIDE POLYMORPHISM
  • P53 PATHWAY
  • SNP309
  • RISK
  • SUSCEPTIBILITY
  • EXPRESSION
  • INHIBITORS
  • SURVIVAL
  • GENE
  • CLL

Cite this